Latest News

• share
• favorite_border

William R. Jacobs, Jr., Ph.D., professor of microbiology & immunology and of genetics at Albert Einstein College of Medicine of Yeshiva University, who is also a Howard Hughes Medical Institute (HHMI) investigator, has been awarded a three-year, $4 million grant from the National Institutes of Health (NIH) to develop a novel genetic strategy for combating tuberculosis (TB). TB causes almost two million deaths each year, making it the world’s most deadly bacterial infection.

• share
• favorite_border

The National Institute of General Medical Sciences (NIGMS) has awarded Albert Einstein College of Medicine of Yeshiva University a five-year, $30 million grant to study the structure and function of thousands of biomedically important proteins.

• share
• favorite_border

A seemingly simple inherited trait – height – springs from hundreds of genetic causes, according to an international team of scientists. The study identified hundreds of gene variants in at least 180 locations that influence adult height.

• share
• favorite_border

Researchers from Albert Einstein College of Medicine of Yeshiva University will hold a congressional briefing in Washington, D.C., aimed at focusing attention on the alarming global diabetes epidemic. Incidence of diabetes is increasing worldwide at a rate that eclipses most other diseases. The World Health Organization estimates that by the year 2030, more than 366 million people will be suffering from diabetes, 10 times the number affected by HIV/AIDS. Of that 366 million, more than 298 million will live in developing countries.

• share
• favorite_border

By constructing a microscope apparatus that achieves resolution never before possible in living cells, researchers at Albert Einstein College of Medicine of Yeshiva University have illuminated the molecular interactions that occur during one of the most important “trips” in all of biology: the journey of individual messenger Ribonucleic acid (RNA) molecules from the nucleus into the cytoplasm (the area between the nucleus and cell membrane) so that proteins can be made.

• share
• favorite_border

A new study by researchers at Albert Einstein College of Medicine of Yeshiva University has provided concrete evidence that children with autism spectrum disorders (ASD) process sensory information such as sound, touch and vision differently than typically developing children.

• share
• favorite_border

Commonly prescribed drugs used to lower blood pressure can actually have the opposite effect—raising blood pressure in a statistically significant percentage of patients. A new study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that doctors could avoid this problem—and select drugs most suitable for their patients—by measuring blood levels of the enzyme renin through a blood test that is becoming more widely available. The study appears in the online edition of the American Journal of Hypertension.

• share
• favorite_border

A study led by a researcher at Albert Einstein College of Medicine of Yeshiva University has revealed a unique “partnership” between two types of bone marrow stem cells, which could lead to advances in regenerative medicine.

• share
• favorite_border

Albert Einstein College of Medicine of Yeshiva University has been named one of the National Institutes of Health’s (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging.

• share
• favorite_border

Scientists at Albert Einstein College of Medicine of Yeshiva University have received a five-year, $10.8 million grant to develop stem cell-based therapies that could be used to mitigate radiation-induced gastrointestinal syndrome – part of acute radiation syndrome (ARS) – for military personnel, first responders and the general public.

• share
• favorite_border

Computerized brain fitness programs are known to help seniors improve their memory and focus. Now, a study led by researchers at Albert Einstein College of Medicine of Yeshiva University has found preliminary evidence that such programs may help frail seniors walk faster, potentially preventing disability and improving quality of life.

• share
• favorite_border

For the third time in four months, the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine of Yeshiva University a research grant aimed at helping people infected with multidrug-resistant tuberculosis.

• share
• favorite_border

The National Cancer Institute has awarded Albert Einstein College of Medicine of Yeshiva University $4.1 million to test the microbicide Carraguard® against the human papillomavirus (HPV), which causes cervical cancer. The research will evaluate the efficacy of Carraguard®, – a clear gel made from the seaweed derivative carrageenan – in preventing new HPV infections in women.

• share
• favorite_border

Keith-Thomas Ayoob, Ed.D., R.D., associate clinical professor of pediatrics and director of the nutrition clinic at the Children’s Evaluation and Rehabilitation Center at Albert Einstein College of Medicine of Yeshiva University, a registered dietitian who advises children and their families, offers seven practical tips that can help parents encourage their kids to eat well during and after school.

• share
• favorite_border

Now that scientists have learned so much about aging through laboratory studies, it’s time to translate those findings into medicines that can benefit our aging population.

• share
• favorite_border

Researchers have linked rejection by a romantic partner to brain activity associated with motivation, reward and addiction cravings, according to a study published in the July issue of the Journal of Neurophysiology.

• share
• favorite_border

Several medical students at Albert Einstein College of Medicine of Yeshiva University have earned coveted fellowships and prestigious awards for the 2010-2011 academic year.

• share
• favorite_border

Using sophisticated genetic analysis, scientists at Albert Einstein College of Medicine of Yeshiva University and New York University School of Medicine have published a study indicating that Jews are a widely dispersed people with a common ancestry. Jews from different regions of the world were found to share many genetic traits that are distinct from other groups and that date back to ancient times.

• share
• favorite_border

The National Institutes of Health (NIH) has awarded scientists at Albert Einstein College of Medicine of Yeshiva University a five-year, $3.9 million grant to study how extensively drug-resistant tuberculosis (XDR-TB) is transmitted in rural South Africa. The findings could alter public health approaches for controlling the XDR-TB epidemic in the developing world.

• share
• favorite_border

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine of Yeshiva University a five-year, $9.5 million grant for the continuation of its Diabetes Research and Training Center (DRTC).

• share
• favorite_border

Steven M. Safyer, M.D., president and chief executive officer of Montefiore Medical Center, the University Hospital and Academic Medical Center for Albert Einstein College of Medicine of Yeshiva University, will deliver this year’s commencement address to Einstein’s class of 2010.

• share
• favorite_border

Leading stem cell and vascular biology researcher Paul S. Frenette, M.D., has been named the first director of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research at Albert Einstein College of Medicine of Yeshiva University. Dr. Frenette will spearhead Einstein’s efforts to build upon existing resources to create a premier stem cell research institute.

• share
• favorite_border

A multi-institutional team of researchers, including scientists at Albert Einstein College of Medicine of Yeshiva University, has received a prestigious National Institutes of Health (NIH) “Glue Grant” to develop a strategy for discovering the structure and function of unknown enzymes identified in genome-sequencing projects.

• share
• favorite_border

Matthew Gamble, Ph.D., assistant professor of molecular pharmacology at Albert Einstein College of Medicine of Yeshiva University, has been awarded a $200,000 Kimmel Scholar Award. He is one of 15 U.S. scientists selected this year by the Kimmel Scholar program, created in 1997 to advance the careers of promising young scientists involved in cancer research. The $200,000 award will fund Dr. Gamble’s innovative research for the next two years.

• share
• favorite_border

Tiny, melanin-covered nanoparticles may protect bone marrow from the harmful effects of radiation therapy, according to scientists at Albert Einstein College of Medicine of Yeshiva University who successfully tested the strategy in mouse models. Infusing these particles into human patients may hold promise in the future. The research is described in the current issue of the International Journal of Radiation Oncology, Biology and Physics.

• share
• favorite_border

Scientists at Albert Einstein College of Medicine of Yeshiva University have determined the crystal structures of two key fluorescent proteins – one blue, one red – used to “light up” molecules in cells. The researchers now have the first roadmap for rationally designing new and differently colored fluorescent proteins to illuminate the structures and processes in living cells.

• share
• favorite_border

Albert Einstein College of Medicine of Yeshiva University has been awarded $10 million from the National Institutes of Health (NIH) to expand its stem cell research capabilities.

• share
• favorite_border

Albert Einstein College of Medicine of Yeshiva University has been awarded $750,000 by the John D. and Catherine T. MacArthur Foundation to study the impact of housing on the cardiovascular health of Latinos in the Bronx.

• share
• favorite_border

In a step towards a possible treatment for Huntington’s disease, scientists at Albert Einstein College of Medicine of Yeshiva University have shown for the first time that the accumulation of a mutated protein may explain damaging cellular behavior in Huntington’s disease.

• share
• favorite_border

A study of nearly 13,000 rescue workers from the Fire Department of the City of New York (FDNY) shows that the significant proportion who suffered acute lung damage after exposure to World Trade Center (WTC) dust have not recovered normal lung function in the years since the September 11, 2001 terrorist attacks.

• share
• favorite_border

Albert Einstein College of Medicine and Ferkauf Graduate School of Psychology, both of Yeshiva University, have announced a collaborative new Master of Public Health (M.P.H.) degree program.

• share
• favorite_border

Mario J. Garcia, M.D., an eminent cardiologist and a leader in the development and clinical implementation of the most advanced, non-invasive cardiac diagnostic technology used around the world today, has been recruited as co-director of the Montefiore-Einstein Heart Center (MEHC) and as chief of Cardiology within the Department of Medicine at Montefiore Medical Center.

• share
• favorite_border

The National Institutes of Health has awarded Albert Einstein College of Medicine of Yeshiva University $1.22 million to combat childhood obesity in the Bronx. Working with Montefiore Medical Center, The University Hospital and Academic Medical Center for Einstein, a team of researchers will build upon their earlier work using education-based audio CDs in the classroom to encourage physical activity and promote positive lifestyle habits.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University have found two novel ways of killing the bacteria that cause tuberculosis (TB), a disease responsible for an estimated two million deaths each year.

• share
• favorite_border

Migraine sufferers are twice as likely to have heart attacks as people without migraine, according to a new study by researchers at Albert Einstein College of Medicine of Yeshiva University.

• share
• favorite_border

A new study shows that a protein found in blood alleviates anemia, a condition in which the body’s tissues don’t get enough oxygen from the blood. In this animal study, injections of the protein, known as transferrin, also protected against potentially fatal iron overload in mice with thalassemia, a type of inherited anemia that affects millions of people worldwide.

• share
• favorite_border

Scientists at Albert Einstein College of Medicine of Yeshiva University have found that a “longevity gene” helps to slow age-related decline in brain function in older adults. Drugs that mimic the gene’s effect are now under development, the researchers note, and could help protect against Alzheimer’s disease.

• share
• favorite_border

Older women with hypertension are at increased risk for developing brain lesions that cause dementia later in life, according to data from the Women’s Health Initiative Memory Study (WHIMS).

• share
• favorite_border

Researchers at the Albert Einstein College of Medicine of Yeshiva University have developed a new approach for treating and healing skin abscesses caused by bacteria resistant to most antibiotics. The study appears in the journal PLoS One.

• share
• favorite_border

Postmenopausal women who take antidepressants face a small but statistically significant increased risk for stroke and death compared with those who do not take the drugs.

• share
• favorite_border

Lisa Marie Nathan, M.D., M.P.H., assistant professor of obstetrics & gynecology and women’s health at Albert Einstein College of Medicine of Yeshiva University, has been awarded a Fulbright Scholar grant for research aimed at reducing Rwanda’s high rate of maternal mortality. Dr. Nathan is the only New York State Fulbright grant recipient in the medical sciences category for the 2009-2010 academic year.

• share
• favorite_border

John J. Foxe, Ph.D., a leading neuroscientist, has been named the first research director of the Children’s Evaluation and Rehabilitation Center (CERC) at Albert Einstein College of Medicine of Yeshiva University.

• share
• favorite_border

Matthew Levy, Ph.D., assistant professor of biochemistry at Albert Einstein College of Medicine of Yeshiva University, has been awarded more than $700,000 by Stand Up To Cancer (SU2C) for his high-risk/high-reward cancer research.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a possible strategy against an invasive parasite that infects more than a quarter of the world’s population, including 50 million Americans.

• share
• favorite_border

A team led by researchers at Albert Einstein College of Medicine of Yeshiva University has found a clear link between living to 100 and inheriting a hyperactive version of an enzyme that rebuilds telomeres – the tip ends of chromosomes. The findings appear in the latest issue of the Proceedings of the National Academy of Sciences.

• share
• favorite_border

Martha S. Grayson, M.D., has been named senior associate dean for medical education at Albert Einstein College of Medicine of Yeshiva University. Dr. Grayson, an alumna of Einstein, is known for developing innovative and rigorous medical educational programs and evaluation processes. She will assume her new leadership position on December 1, 2009.

• share
• favorite_border

Sustaining modest weight loss for 10 years, or taking an anti-diabetic drug over that time, can prevent or lower the incidence of type 2 diabetes in people at high risk for developing the disease, according to the Diabetes Prevention Program Outcomes Study (DPPOS), a long-term follow-up to a landmark 2001 diabetes prevention study.

• share
• favorite_border

The survey ranks Einstein 3rd out of 94 U.S. academic institutions.

• share
• favorite_border

The fact that they eat a lot – and often – may explain why most people and other mammals are protected from the majority of fungal pathogens, according to research from Albert Einstein College of Medicine of Yeshiva University.

• share
• favorite_border

Lynne Holden, M.D., associate professor of clinical emergency medicine at Albert Einstein College of Medicine of Yeshiva University, has been named a Robert Wood Johnson Foundation Community Health Leader (CHL) for her work with Mentoring in Medicine. Dr. Holden is co-founder and president of the organization, which encourages disadvantaged students to enter the health professions. Dr. Holden is one of 10 honorees who received the CHL Award at a ceremony held in the Mayflower Hotel in Washington, D.C. earlier today.